USE OF DALBAVANCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS

被引：0
|
作者：
Hernandez, I [1 ]
Carcedo, D. [1 ]
Sabaniego, J. [2 ]
Rossello, I [2 ]
Jimenez, A. [3 ]
机构：
[1] Hygeia, Madrid, Spain
[2] Angelini Pharma Espana SLU, Barcelona, Spain
[3] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE669
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [41] The safety of treatment options for acute bacterial skin and skin structure infections
    Bassetti, Matteo
    Peghin, Maddalena
    Castaldo, Nadia
    Giacobbe, Daniele Roberto
    [J]. EXPERT OPINION ON DRUG SAFETY, 2019, 18 (08) : 635 - 650
  • [42] Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections
    Beresford, Eric
    Biek, Donald
    Jandourek, Alena
    Mawal, Yogesh
    Riccobene, Todd
    Friedland, H. David
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (02) : 123 - 135
  • [43] TEDIZOLID PHOSPHATE FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS
    Gras, J.
    [J]. DRUGS OF TODAY, 2014, 50 (11) : 729 - 737
  • [44] Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
    Alejandro Garcia-Robles, Ana
    Lopez Briz, Eduardo
    Fraga Fuentes, Maria Dolores
    Asensi Diez, Rocio
    Sierra Sanchez, Jescis Francisco
    [J]. FARMACIA HOSPITALARIA, 2018, 42 (02) : 73 - 81
  • [45] Treatment of bacterial skin and skin structure infections
    Guay, DRP
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1259 - 1275
  • [46] The optimal duration of treatment for skin and soft tissue infections and acute bacterial skin and skin structure infections
    Corcione, Silvia
    De Rosa, Francesco Giuseppe
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (02) : 155 - 162
  • [47] Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
    Daniela Zinzi
    Ioanna Vlachaki
    Edel Falla
    Theo Mantopoulos
    Dilip Nathwani
    [J]. The European Journal of Health Economics, 2022, 23 : 1371 - 1381
  • [48] Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
    Zinzi, Daniela
    Vlachaki, Ioanna
    Falla, Edel
    Mantopoulos, Theo
    Nathwani, Dilip
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (08): : 1371 - 1381
  • [49] Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
    Gonzalez, Pedro L.
    Rappo, Urania
    Mas Casullo, Veronica
    Akinapelli, Karthik
    McGregor, Jennifer S.
    Nelson, Jennifer
    Nowak, Michael
    Puttagunta, Sailaja
    Dunne, Michael W.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 471 - 481
  • [50] Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
    Pedro L. Gonzalez
    Urania Rappo
    Veronica Mas Casullo
    Karthik Akinapelli
    Jennifer S. McGregor
    Jennifer Nelson
    Michael Nowak
    Sailaja Puttagunta
    Michael W. Dunne
    [J]. Infectious Diseases and Therapy, 2021, 10 : 471 - 481
12345